Anti-Spike-RBD mAb

• CAT Number: I044223
• Purity: ≥95%

Anti-Spike-RBD mAb（Cat No.:I044223）is a monoclonal antibody that specifically targets the receptor-binding domain (RBD) of the spike (S) protein of coronaviruses such as SARS-CoV and SARS-CoV-2. By binding to the RBD, it blocks the interaction between the spike protein and the host ACE2 receptor, thereby preventing viral entry into host cells. This neutralizing action makes it a valuable therapeutic and diagnostic tool in managing coronavirus infections. Anti-Spike-RBD mAbs are widely used in research, vaccine development, and as part of antibody-based treatments to reduce viral load and disease severity.